the apparent greater sensitivity to the drug of peripheral blood than bone marrow t lymphocytes , possibly related to a different distribution of t colony-forming cells or of t lymphocyte subsets , may have some bearing on the clinical application of cyclosporin a in the prevention and treatment of graft-versus-host disease in man .
C0010592
cyclosporin a
C0018133
graft-versus-host disease